Related Experiment Video
Updated: Aug 19, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Fas-associated factor-1 mediates chemotherapeutic-induced apoptosis via death effector filament formation
Min-Young Park1, Seung-Wook Ryu, Kwang Dong Kim
1Research Center for Biomedicinal Resources and Department of Genetic Engineering, PaiChai University, Daejeon, Korea.
Abstract:
Fas-associated factor-1 (FAF1) is a newly introduced member of the Fas death-inducing signaling complex and potentiates Fas-mediated apoptosis. Clinical study has revealed that FAF1 is significantly reduced in gastric carcinomas. The present study demonstrates that FAF1 mediates chemotherapeutic-induced apoptosis via participation in the formation of death effector filament (DEF), a cytoskeleton-like structure found in receptor-independent apoptosis. Overexpression of FAF1 enhanced DEF assembly and cell death induced by chemotherapeutics such as staurosporine (STS), cisplatin (CDDP) and etoposide (VP16). FAF1 sensitized cells to STS, CDDP and VP16 in dose- and time-dependent manner. Introduction of antisense FAF1 construct inhibited DEF assembly and chemotherapeutic-induced apoptosis. Analysis using FAF1 truncates showed that the FAF1 domain interacting with DEDs of FADD and caspase-8 was sufficient to enhance DEF assembly. Confocal microscopy revealed that FAF1 was present in DEFs together with FADD and caspase-8. Collectively, our data provide a molecular mechanism for the chemosensitization by FAF1 (i.e., mediating DEF assembly).
Insights
Fas-associated factor-1 (FAF1) enhances chemotherapy effectiveness by promoting the formation of death effector filaments (DEF), crucial for programmed cell death. Reduced FAF1 levels in gastric cancer highlight its potential role in treatment resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Fas-associated factor-1 (FAF1) is implicated in Fas-mediated apoptosis and its levels are reduced in gastric carcinomas.
- Understanding FAF1's role in apoptosis is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the mechanism by which FAF1 mediates chemotherapeutic-induced apoptosis.
- To elucidate FAF1's role in the formation of death effector filaments (DEF).
Main Methods:
- Overexpression and antisense FAF1 constructs were used in cancer cells.
- Cells were treated with chemotherapeutics like staurosporine (STS), cisplatin (CDDP), and etoposide (VP16).
- DEF assembly was analyzed using confocal microscopy, and FAF1 truncates were employed to identify functional domains.
Main Results:
- FAF1 overexpression enhanced DEF assembly and apoptosis induced by STS, CDDP, and VP16.
- FAF1 sensitized cells to chemotherapeutics in a dose- and time-dependent manner.
- The FAF1 domain interacting with FADD and caspase-8 was sufficient for enhancing DEF assembly, with FAF1, FADD, and caspase-8 co-localizing in DEFs.
Conclusions:
- FAF1 mediates chemotherapeutic-induced apoptosis through its role in DEF assembly.
- FAF1 acts as a molecular mechanism for chemosensitization, offering potential therapeutic targets for gastric cancer.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Caspases
Anaphase Promoting Complex

